“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Brief view
Pharmaceutical factory Joint Stock Company
“Borisovskiy Zavod Medicinskikh Preparatov” is the leading
manufacture and the exporter of broad-spectrum drugs in
the Republic of Belarus.
The factory was established in 1965. The company
town of “Borisovskiy Zavod Medicinskikh Preparatov” JSC
is above 11 hectares. Total employment at the factory is
2700 persons. Production volume in the actual prices for
2013 – 917.3 billion rubles (103.3 million USD)
Now
JCS
“Borisovskiy
Zavod
Medicinskikh
Preparatov” is a modern dynamically developing
pharmaceutical factory with new technology and high
quality production and skilled personal.
slide 1
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Brief view
JSC“BZMP” holds participating shares in the companies:
“Borisovskiy Zavod
Medicinskikh
Preparatov” JSC
Belarus- German JV
Fresenius-BorisovDialysetechnik
(JV “FREBOR”
OOO)
Participating shares
of JSC “BZMP”
– 78.2%
OOO “Borisov KZ”
(Kazakhstan)
Participating shares
of JSC
“BZMP”– 30%
BORIMED LTD
(Kyrgyzstan)
Participating shares
of JSC
“BZMP”– 50%
OOO “Boripharm” (RF)
Participating shares
of JSC
“BZMP”– 100%
slide 2
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
slide 3
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Brief view
The core business of “Borisovskiy Zavod
Medicinskikh Preparatov” JSC
• Ampoule production and powder for injections in
vials (antibiotics)
• tablet production
• production of liquid photochemical and soft
medical drugs
• production of hard capsule drugs
slide 4
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Short summary
Production volume in comparable prices
Billions rubles / growth rate to the previous year
917
122,5%
1 000
900
748
174,4%
700
billons rubls
Billons rubles
800
600
500
400
300
181
128,1%
243
134,3%
429
176,4%
200
100
0
2009
64,8 млн.$
2010
2011
2012
2013
103,3 млн.$
time
Production volume in the actual prices in 2012- 747,8 billions rubles, in 2013
– 917,3 billion rubles (103,3 million USD).
slide 5
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
7) 1,2%
8) 1,3%
Production pattern for 2013
Production pattern of quantities for
2013,
thousand pieces
1) vacuum filled ampoules
9) 0,5%
2) tablets
6) 1,6%
3) GMP ampoules
10) 0,3%
4) antibiotics in vials
5) 1,4%
11) 0,2%
4) 3,0%
12) 0,3%
5) iodine preparation
6) ointment, cream, gel (in tubes)
7) tinctures
3) 12,8%
8) capsule production
9) alcohol solution
10) oils
2) 27,4%
1) 50,4%
11) syrups and mixtures
12) others
slide 6
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Export pattern
Republic of Belarus
Russian Federation
Kazakhstan
Uzbekistan
Tajikistan
Turkmenistan
Kyrgyzstan
Ukraine
Moldova
Armenia
Latvia
Lithuania
Estonia
Azerbaijan
Georgia
Production was exported to 24 regions
including CIS countries, Russia,
nearby and foreign countries .
Vietnam
DPRK
EGYPT
Afghanistan
USA
Iraq
Somalia
Yemen
Lebanon
Macedonia
slide 7
Portion of JSC “BZMP” in total
domestic production of medical drugs
for 2013
(million packs)
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
90,00
80,00
1.
74,0
2.
Belmedpreparaty
RUE
3.
Farmland JS OOO
70,00
million packs
60,00
BZMP JSC
54,0
4.
50,00
Ekzon RUE
5. Lekfarm SOOO
40,00
6.
30,00
Nesvizskiy ZMP
7. Pharmtekhnologia
16,5
20,00
15,1
13,0
11,5
8.
11,3
7,7
10,00
4,9
9.
Minskintercaps RUE
DIALEK RUE
0,00
1
2
3
4
5
6
7
8
9
BZMP JSC keeps 36% of sales of medical drugs sold by domestic in the
Republic of Belarus (on the basis of quantities).
slide 8
“Borisovskiy Zavod
Portion
Medicinskikh Preparatov” JSC
of BZMP JSC in total sales of medical
drugs in the Republic of Belarus
for 2013 (million packs)
90,0
1. BZMP JSC
2. Belmedpreparaty RUE
3. Farmland JS OOO
80,0
4. Ekzon Rue
74,0
5. Lekf arm SOOO
6. Nesvuzhskiy ZMP
70,0
7.Pharmtechnology
8. LubnyPharm
60,0
9.Pharmack
10. Pharmstandart
54,0
11. Minskintercaps
million packs
50,0
12. Berlin-Chemie
13. Dialeck
14. Luganskiy
40,0
15. Gedeon Richter
16. Sanof i Aventis
17.Mediosorb
30,0
18. Borshchahivskiy CPD
19. Bayer Consumer
20,0
16,5
20. NatureProdukt
15,1
13,0
21. Takeda
11,5 11,3
22. D-r Reddis
9,1
10,0
7,9
7,8
7,7
23.Actavis
5,3
4,9
4,8
4,4
4,2
4,2
3,6
3,6
3,5
3,5
3,2
2,9
2,8
2,7
24.KRKA
25.Gitomirskaya
0,0
1
2 3 4 5
producers
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
BZMP JSC keeps 26% for sales of medical drugs in the Republic of
Belarus (on the basis of quantities)
slide 9
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Export pattern
Export ratio (%) in total volume exports
for 2013, thousand USD
Russian Federation (52,9%)
Uzbekistan (2,2%)
Turkmenistan (3,2%)
Ukraine (0,4%)
Armenia (1,1%)
Georgia (2,5%)
Kazakhstan (25,4%)
Azerbaijan (6,0%)
Kyrgyzstan (1,5%)
Moldova (2,5%)
Tajikistan (1,1%)
Foreign countries (USA, Afghanistan, Estonia, Latvia) (1,2%)
Kazakhstan
Uzbekistan
Russian Federation Azerbaijan
Turkmenistan
Kyrgyzstan
Moldova
Ukraine
Tajikistan
Armenia
Georgia
Foreign countries
In 2013 export of production amounted to 55.4 million USD.
slide 10
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Volume of export
Volume of exports
60,0
44,4
124,5%
50,0
millions dollars
40,0
47,6
107,4%
52,5
110,2%
55,4
105,6%
35,6
106,2%
30,0
20,0
10,0
0,0
2009
2010
2011
2012
2013
года
In 2013 export volume amounts to 55.4 million US
dollars or 105.6 % of the corresponding period last
year.
slide 11
TOP - 10
of medical drugs
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Rating place
Name
Sales volume for 2013
(local sales + export)
In thousand USD
1
Valeriane extract, coated tablets 20 mg, №50
2
Acetylsalicylic acid, tablets 500 mg №10
3
Ceftriaxone, powder for injections, 1 g
3436
4
Analgin 50% №10
2553
5
Citramon-Borimed, tablets №6
2488
6
4527
3639
Sodium chloride, 0,9% solution for injections, 5ml №10
1859
7
Cefazolin, powder for injections, 1 g
8
Folic acid, tablets №50
9
Lidocaine, solution for injections 2 ml
1590
10
Cyanocobalamin , solution for injections
1502
1833
1655
slide 12
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
DEALERS NET
“Borisovskiy Zavod
Medicinskikh Preparatov”JSC
Structure of dealer net
Foreign countries
Tajikistan
Georgia
Kazakhstan
Turkmenistan
Ukraine
Azerbaijan
Kyrgyzstan
Russian Federation
Moldova
Uzbekistan
№
п/п
Country
Number of
dealers
1
Kazakhstan
23
2
Russian Federation
10
3
Uzbekistan
10
4
Moldova
11
5
Georgia
7
6
Azerbaijan
7
7
Other foreign
countries
14
8
Turkmenistan
4
9
Kyrgyzstan
3
10
Tajikistan
5
11
Ukraine
2
12
Armenia
2
Total
98
slide 13
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
New medical drugs
Name of drug
Pharmacologic
2009
Zovasticor, tabl.
Hypolipemic (lowers the level of cholesterol in the blood)
Chloropiramin, sol. for ing.
Antihistamine preparation, inhibitor of H1- histamine receptors
Lidocaine, sol. for ing.
For solution of cephalosporin antibiotics of III generation
Spasmatone, sol. for ing., tabl
Analgesics and antispasmodics, non-narcotic
Ketozoral, tabl.
Anti-fungous
Roxitromicyn – Borimed, tabl.
Antibiotic macrolide
2010
Borinem, sol. for ing.
Antibiotic carbopenem
Aspicard, tabl.
Non-steroidal anti-inflammatory drugs – acetilsalicylic acid
Lansazole, caps.
Inhibitor of proton pump
BoriVit, sol. for ing.
Hypoglycemic means, decreases sugar in blood
Klindacil, sol. for ing.
Antibiotic lincosamides group
2011
Lizinopril-Borimed,tabl.
Inhibitor ACE (arterial hypertension, chronicle heart dysfunction)
Ribavirin-Borimed, caps.
Intivirus preparation
Metformin-Borimed, tabl.
For hypoglycemia treatment, per oral use, group Biguanid
Risperidon-Borimed, tabl.
Antipsychotic
Sulpirid, caps.
Antipsychotic
Sedative drops
Combined sedative preparation
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
New medical drugs
New medical drugs
Pharmacologic
Name of drug
2012
combined antimicrobial agent for dentistry use
Metromizol-Dent, gel
Gliclazide, tabl.
2nd generation sulfonylurea antidiabetic agent
Clindacyl, caps.
lincosamide antibiotic
Clarithromycin, tabl.
macrolide antibiotic
Bisoprolol, tabl.
hypotensive, antiarrythmic and antianginal remedy
Ondansetron, tabl.
antiemetic agent
Ethambutol, tabl.
antituberculous remedy
Choline Alfascerate, sol. for
nootropic agent
inj.
slide 15
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
New medical drugs
New medical drugs
Pharmacologic
Name of drug
2013
Valerianae Forte, tabl.
sedative and soporific
Wite tablet, tabl.
enterosorbent additional source of dietary fiber
ProctoMaz ointment
agent for the treatment of hemorrhoids
Meloxicam, tabl.
non-steroidal anti-inflammatory drug
Magnekard,tabl.
platelet aggregation inhibitors
slide 16
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Sales volume pattern in the Republic of
Belarus for 2013
Enterprises of TP RUP “Pharmacia”
- 366,5 bln. rubles
11,8
4,1
Direct shipments (hospitals, clinics,
drugstores)- 17,9 bln. rubles
84,1
Other shipments (commercial
enterprises) - 51,1 bln. rubles
Increase of sales for 2013(compared to 2012):
Total increase of sales for 2013 – 130,7% (compared to 2012)
Amounts to 435.6 billion rubles ( 49.0 mln. USD)
slide 17
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Implementation of
international standards
All main production sectors have GMP certificate and
monitored in accordance with the quality standards of GMP.
The factory was certified with:
• Quality and Operational Health and Safety Management Quality
Management Systems for medical drugs and biologically active
additives conformity STB ISO 9001 -2009.
• Environment Management Systems for production and sales of
medical drugs (ecological certificate) STB ISO 14001:2005
• Occupational Health & Safety System Certification for production
and sale of medical drug and biologically active additives - STB
18001-2009
• Certificate of Conformity for Production of Valeriane extract tablets
accordingly to the EC standards issued by Latvian Certification
Centre.
slide 18
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Award of the government of the
Republic of Belarus
Award of government of the
Republic of Belarus in the field
quality 2011 is awarded to open
joint stock company ‘Borisovskiy
Zavod Medicinskikh Preparatov”.
The company is awarded for its
high efficient quality
management and assurance of
production of quality competitive
products.
slide 19
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Proposal on cooperation
We offer to create a joint venture on the basis of existing sites of JSC
“BZMP”:
1. Joint venture for production of solutions for injections in ampoules
Collective investment fund – 45.5 mln USD
Participant’s quotas:
JSC “BZMP” – 25.5 mln USD – 56.0%
Investor
– 20.0 mln USD – 44.0%
JSC “BZMP”:
a) hands over its existing production sites and equipment for production of
solutions for injections in ampoules;
b) hands over the whole range of products in the form of solutions for
injections.
Investor:
a) pays the cost of the reconstruction of ampoule production;
b) offers a new range of medical products.
slide 20
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Proposal on cooperation
2. Joint venture for production of medical products in the form of
tablets
Collective investment fund – 23.2 mln USD
Participant’s quotas:
JSC “BZMP” – 8.2 mln USD – 35.4%
Investor
– 15.0 mln USD – 64.6%
JSC “BZMP”:
a) hands over a part of its existing production sites and equipment for
production of medical products in the form of tablets;
b) hands over a part of the range of products in the form of tablets.
Investor:
a) pays the cost of the reconstruction of existing tablet production;
b) offers a new range of medical products.
We invite you for cooperation!
slide 21
“Borisovskiy Zavod
Medicinskikh Preparatov” JSC
Health, the dearest
value is trusted to
us !
slide 22